Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Carr's Group: Recovery Continues

Published 04/16/2018, 04:36 AM
Updated 07/09/2023, 06:31 AM

The recovery in both US feed block sales and the UK manufacturing businesses noted at Carr’s Group's (LON:CARRC) AGM in January has continued throughout H118. This has resulted in a 22% improvement in adjusted PBT year-on-year and a slight over-performance compared with management’s expectations. H218 has started well, so we raise our estimates and adjust our indicative valuation from 167p/share to 169p/share.

Recovery Continues

Improved performance in both divisions

The positive trends noted at the AGM in January continued for the remainder of H118. Group revenues rose by 13.2% year-on-year to £200.1m. This reflected a recovery in the US feed block activity linked to an improvement in cattle prices and in the UK manufacturing businesses, as work progressed on the major contract that had been delayed right until the end of FY17. In addition, sentiment in the UK farming sector continued to be positive and the remote handling businesses benefited from strong order books relating to the global nuclear industry. Pre-exceptional PBT grew by 22.0% to £10.9m. The integration of NuVision, the US engineering company acquired in August 2017, is progressing well.

To read the entire report Please click on the pdf File Below:

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.